Sep 2, 2025, 07:03
AstraZeneca Marks Blood Cancer Awareness Month With Focus on CLL Community
AstraZeneca shared a post on LinkedIn:
“Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia, yet many aspects of the patient experience remain overlooked.
As Blood Cancer Awareness Month begins, we recognise the vital role of the CLL community, including patient organisations such as the CLL Advocates Network, in strengthening health literacy and empowering informed decisions. We can help improve outcomes and support those affected by CLL and other complex blood cancers by working together.
Proceed to the video attached to the post.
More posts featuring AstraZeneca on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 10:02
Sep 2, 2025, 09:56
Sep 2, 2025, 09:42
Sep 2, 2025, 09:40
Sep 2, 2025, 09:20
Sep 2, 2025, 09:11
Sep 2, 2025, 08:58
Sep 2, 2025, 08:42